Oishi Koichi, Itamoto Toshiyuki, Amano Hironobu, Fukuda Saburo, Ohdan Hideki, Tashiro Hirotaka, Shimamoto Fumio, Asahara Toshimasa
Department of Surgery, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan.
J Surg Oncol. 2007 Mar 15;95(4):311-6. doi: 10.1002/jso.20661.
Clinicopathologic features of poorly differentiated hepatocellular carcinoma (HCC) have not been elucidated. The purpose of this study was to clarify the characteristics of poorly differentiated HCC in hepatectomized patients.
From 1986 to 2001, 354 HCC patients underwent curative hepatectomy in our institution and were prospectively followed. Histological examinations revealed 43 well-differentiated HCC tumors, 273 moderately differentiated HCC tumors, and 38 poorly differentiated HCC tumors. Clinicopathologic factors and outcomes after hepatectomy were compared statistically.
Only serum alpha-fetoprotein level was significantly different in the poorly differentiated HCC group from that in the moderately differentiated HCC group preoperatively (P=0.0001). Although there were no significant differences between overall survival rates or between disease-free survival rates in the three groups, distant metastasis within 2 years after hepatectomy occurred more frequently in the poorly differentiated HCC group (21%) than in the well-differentiated HCC group (2%) (P=0.011) or moderately differentiated HCC group (8%) (P=0.018). Distant metastasis occurred in about 40% of patients in the poorly differentiated HCC group with tumor size greater than 3 cm.
Poorly differentiated HCC tumors larger than 3 cm are already of advanced stage representing distant metastasis in the early period after hepatectomy.
低分化肝细胞癌(HCC)的临床病理特征尚未阐明。本研究的目的是明确接受肝切除患者中低分化HCC的特征。
1986年至2001年,354例HCC患者在本机构接受了根治性肝切除术,并进行了前瞻性随访。组织学检查显示43例高分化HCC肿瘤、273例中分化HCC肿瘤和38例低分化HCC肿瘤。对肝切除术后的临床病理因素和结果进行统计学比较。
术前低分化HCC组与中分化HCC组相比,仅血清甲胎蛋白水平有显著差异(P = 0.0001)。虽然三组的总生存率或无病生存率之间无显著差异,但低分化HCC组肝切除术后2年内远处转移的发生率(21%)高于高分化HCC组(2%)(P = 0.011)或中分化HCC组(8%)(P = 0.018)。肿瘤大小大于3 cm的低分化HCC组中约40%的患者发生远处转移。
大于3 cm的低分化HCC肿瘤在肝切除术后早期已处于晚期,表现为远处转移。